Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 377

Results For "sign"

4873 News Found

Piramal Pharma Solutions upgrades Pithampur site
News | May 25, 2022

Piramal Pharma Solutions upgrades Pithampur site

New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses


Sputnik V demonstrates strong protection against Omicron variant
Biotech | May 25, 2022

Sputnik V demonstrates strong protection against Omicron variant

The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.


Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries
News | May 25, 2022

Pfizer offers patent-protected medicines on not-for-profit to 45 low income countries

Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap


Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
Digitisation | May 24, 2022

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool

The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs


Vaxzevria approved in the EU as third dose booster against Covid-19
Drug Approval | May 23, 2022

Vaxzevria approved in the EU as third dose booster against Covid-19

Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine


CHMP recommends European Commission approval of Rinvoq
Drug Approval | May 23, 2022

CHMP recommends European Commission approval of Rinvoq

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients


Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape
Biotech | May 23, 2022

Crosscope and Farcast Biosciences join efforts to reshape the precision oncology landscape

The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer


50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear


Dapagliflozin met primary endpoint in DELIVER Phase III trial
Biotech | May 23, 2022

Dapagliflozin met primary endpoint in DELIVER Phase III trial

Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction


New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks
Biotech | May 23, 2022

New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks

Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment